TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICE

Objective: to estimate the frequency of use of antiosteoporotic drugs in daily clinical practice and treatment adherence in patients. Subjects and methods. Questionnaires were used to interview two patient groups: 1) 198 women with osteoporosis (OP) with duration ≥3 years; 2) 186 women over 50 years...

Full description

Saved in:
Bibliographic Details
Main Authors: N. V. Toroptsova, O. A. Nikitinskaya, O. V. Dobrovolskaya
Format: Article
Language:Russian
Published: IMA PRESS LLC 2014-06-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1949
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849243556111187968
author N. V. Toroptsova
O. A. Nikitinskaya
O. V. Dobrovolskaya
author_facet N. V. Toroptsova
O. A. Nikitinskaya
O. V. Dobrovolskaya
author_sort N. V. Toroptsova
collection DOAJ
description Objective: to estimate the frequency of use of antiosteoporotic drugs in daily clinical practice and treatment adherence in patients. Subjects and methods. Questionnaires were used to interview two patient groups: 1) 198 women with osteoporosis (OP) with duration ≥3 years; 2) 186 women over 50 years of age who had sustained low-trauma fractures (LTF) at different sites and undergone assessments of therapy prescription and adherence 12 and 18 months after fracture. Results. In Group 1 patients with OP, 16, 24, and 38% of the women took antiosteoporotic treatment for >3, 2-3, and 6 months to 1 year, respectively; and 22% did not start pathogenetic therapy. Treatment adherence was significantly higher among those who were followed at the specialized OP Center. In Group 2, 56% of the patients had received therapy following LTF and 44% had not, which was due to the absence of primary care physicians' recommendations in half of the cases. 24% were treated after LTF within the first year and only 19% of the women were at 18 months. Treatment was recommended by the specialists of the OP Center in 89% of the cases and by primary care physicians in 11%. Within a year, repeated fracture occurred in 9% of the patients; among them none received pathogenetic treat- ment. A questionnaire survey of the patients indicated that they preferred to use drugs more rarely rather than every day. At the same time no advantages of any one route of drug administration were found. Conclusion. There is a low frequency of using pathogenetic treatment in patients with OP, particularly in those who are followed up in the district outpatient departments, which is due to both the absence of physicians' prescription of antiosteoporotic drugs and inadequate treatment adherence in patients. Both patient motivation to long-term treat- ment and OP education programs among primary care physicians are needed to improve the quality of medical care to osteoporotic patients.
format Article
id doaj-art-b330b9c5dadd4f85b9fe96a2ac46b8ee
institution Kabale University
issn 1995-4484
1995-4492
language Russian
publishDate 2014-06-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-b330b9c5dadd4f85b9fe96a2ac46b8ee2025-08-20T03:59:26ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922014-06-0152333634110.14412/1995-4484-2014-336-3411883TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICEN. V. Toroptsova0O. A. Nikitinskaya1O. V. Dobrovolskaya2Nasonova Research Institute of Rheumatology, Moscow, RussiaNasonova Research Institute of Rheumatology, Moscow, RussiaNasonova Research Institute of Rheumatology, Moscow, RussiaObjective: to estimate the frequency of use of antiosteoporotic drugs in daily clinical practice and treatment adherence in patients. Subjects and methods. Questionnaires were used to interview two patient groups: 1) 198 women with osteoporosis (OP) with duration ≥3 years; 2) 186 women over 50 years of age who had sustained low-trauma fractures (LTF) at different sites and undergone assessments of therapy prescription and adherence 12 and 18 months after fracture. Results. In Group 1 patients with OP, 16, 24, and 38% of the women took antiosteoporotic treatment for >3, 2-3, and 6 months to 1 year, respectively; and 22% did not start pathogenetic therapy. Treatment adherence was significantly higher among those who were followed at the specialized OP Center. In Group 2, 56% of the patients had received therapy following LTF and 44% had not, which was due to the absence of primary care physicians' recommendations in half of the cases. 24% were treated after LTF within the first year and only 19% of the women were at 18 months. Treatment was recommended by the specialists of the OP Center in 89% of the cases and by primary care physicians in 11%. Within a year, repeated fracture occurred in 9% of the patients; among them none received pathogenetic treat- ment. A questionnaire survey of the patients indicated that they preferred to use drugs more rarely rather than every day. At the same time no advantages of any one route of drug administration were found. Conclusion. There is a low frequency of using pathogenetic treatment in patients with OP, particularly in those who are followed up in the district outpatient departments, which is due to both the absence of physicians' prescription of antiosteoporotic drugs and inadequate treatment adherence in patients. Both patient motivation to long-term treat- ment and OP education programs among primary care physicians are needed to improve the quality of medical care to osteoporotic patients.https://rsp.mediar-press.net/rsp/article/view/1949osteoporosis, osteoporotic fractures, treatment adherence.
spellingShingle N. V. Toroptsova
O. A. Nikitinskaya
O. V. Dobrovolskaya
TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICE
Научно-практическая ревматология
osteoporosis, osteoporotic fractures, treatment adherence.
title TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICE
title_full TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICE
title_fullStr TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICE
title_full_unstemmed TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICE
title_short TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICE
title_sort treatment adherence in patients with osteoporosis in daily clinical practice
topic osteoporosis, osteoporotic fractures, treatment adherence.
url https://rsp.mediar-press.net/rsp/article/view/1949
work_keys_str_mv AT nvtoroptsova treatmentadherenceinpatientswithosteoporosisindailyclinicalpractice
AT oanikitinskaya treatmentadherenceinpatientswithosteoporosisindailyclinicalpractice
AT ovdobrovolskaya treatmentadherenceinpatientswithosteoporosisindailyclinicalpractice